Management Team

The core medical science team - with Sloan Kettering heritage, New York Medical College appointments, Cornell University and NY Presbyterian posts - created the intellectual property behind Capridine and Provax

• They are backstopped by an advisory dream team of prominent Oncologists, Geneticists, Cellular Biologists and Immunologists

• From the Cancer Institute of NJ, BU, Baylor, Merck and Agenus. Management is supplemented by a team of public company professionals and advisors to guide AVT from its development stage through profitable operations and value growth.

Abraham Mittelman, MD - Chairman of the Board

Robert K. Gardner – Member of the Board

Morton Coleman MD - Advisor to the Board

Raj Kumar Tiwari, PhD -
Chief Scientific Officer, Chair of the Science Board & Director

Jan Geliebter, PhD - Secretary